With the expiry of patents for several essential medicines, the prices of key drugs, including those for diabetes, asthma, ...
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
One of the ways diabetes can affect the body is by overstimulating the sweat glands. Because of this, it's harder to maintain a steady internal body temperature. Extreme fluctuations in blood sugar ...
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:50 Hrs [IST] Corona Remedies Limited ha ...
Mankind Pharma launches affordable empagliflozin in India for diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:30 Hrs [IST] Mankind Pharma has launched its affordable gen ...
Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney ...
The price of empagliflozin, a commonly prescribed diabetes drug, has been slashed by a staggering 90% in India. This ...
Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...
The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...
Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...
Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results